Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
US10130595B2 · kind B2 · utility
2Cited by
11References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 3, 2015 |
| Grant date | Nov 20, 2018 |
| Priority date | — |
| Expiry date | Dec 3, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a disease selected from the group consisting of cancer, Duchenne muscular dystrophy, AIDS, and progeria, that includes administering to a patient in need thereof an effective quantity of at least one compound of formula (IV) or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.